Literature DB >> 3886340

[Healing rates following omeprazole and ranitidine treatment of gastric ulcer. Results of a German multicenter study].

M Classen, H G Dammann, W Domschke, W Hüttemann, W Londong, M Rehner, T Scholten, B Simon, L Witzel, J Berger.   

Abstract

The effectiveness of omeprazole (20 mg orally each morning) or ranitidine (150 mg orally twice daily) in the treatment of gastric ulcer was compared in 184 out-patient in a randomized, endoscopically controlled multi-centre double-blind ("double dummy") trial. Healing rates with omeprazole after two, four and eight weeks were 43, 81 and 95%, respectively, those with ranitidine were 45, 80 and 90%, a statistically not significant difference. Independently of medication, small ulcers (less than 8 mm diameter) healed more quickly than larger ones. Ulcers in the body of the stomach responded poorest to both drugs. Smoking had no statistically significant effect on healing rate. Omeprazole and ranitidine had similarly favourable effects on symptoms. Neither side effects nor changes in biochemical parameters could be ascribed to omeprazole. Both drugs had equivalent effects on the healing of gastric ulcers in the stated dosages.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3886340     DOI: 10.1055/s-2008-1068876

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  12 in total

1.  Short-term treatment of gastric ulcer. A meta-analytical evaluation of blind trials.

Authors:  F Di Mario; G Battaglia; G Leandro; G Grasso; F Vianello; S Vigneri
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Omeprazole and cimetidine in treating ulcers of the body of the stomach.

Authors:  V Savarino; G S Mela; G Celle
Journal:  BMJ       Date:  1989-05-06

Review 3.  Omeprazole. Overview and opinion.

Authors:  S Holt; C W Howden
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

Review 4.  Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.

Authors:  D McTavish; M M Buckley; R C Heel
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

Review 5.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

6.  A single night time dose of ranitidine in the acute treatment of gastric ulcer: a European multicentre trial.

Authors:  F P Ryan; R Jorde; R S Ehsanullah; K Summers; J R Wood
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

Review 7.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

8.  Healing of gastric body ulcer with gastroprotective versus antisecretory treatment.

Authors:  M Jablonská
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

9.  Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?

Authors:  P Bauerfeind; T Cilluffo; C J Fimmel; C Emde; C von Ritter; W Kohler; R Gugler; T Gasser; A L Blum
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

10.  Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial.

Authors:  K Lauritsen; S J Rune; H R Wulff; J H Olsen; L S Laursen; T Havelund; L Astrup; F Bendtsen; J Linde; P Bytzer
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.